• No se han encontrado resultados

4.4 PRUEBAS PARA DETERMINAR EL EFECTO DE INHIBICIÓN SOBRE

4.4.2 PRUEBA DE AZUL DE METILENO (MBT)

4.4.3.1 Orteguaza

3.2.1 Abstract

Heterogeneous mutations in the fibroblast growth factor receptor 2 gene (FGFR2) cause a range o f craniosynostosis syndromes. The specificity o f the Apert cranial phenotype reflects its narrow mutational range, in that 98% o f Apert cases result from the Ser252Trp or the Pro253Arg mutations in the FGFR2 — Ig llla extracellular subdomain. In contrast, a broad range o f mutations throughout the extracellular domain o f FG FR2 causes the overlapping cranial phenotypes o f Pfeiffer, Crouzon, and related craniofacial dysostoses.

The expression o f F G F R l, the Igllla/c and Igllla/b isoforms o f FGFR2, and FGFR3 is investigated in Apert (P253R) and Pfeiffer (C278F) foetal cranial tissue and contrasted with normal human controls. FGFR1 and FGFRJ are normally expressed at 14 — weeks in the cells o f the periosteum and osteoid, in domains overlapped by that o f FGFR2, which widely includes pre — osseous cranial mesenchyme. FGFR2 expression is, however, restricted to domains o f advanced osseous differentiation in both Apert and Pfeiffer cranial

skeletogenesis, in the presence o f FG F2 but n ot FG F4 or FGF7. Whereas expression o f the

FGFR2-IgIIIa/b (KGFR) isoform is restricted in normal human cranial osteogenesis, there is preliminary evidence that KGFR is ectopicaHy expressed in Pfeiffer cranial osteogenesis.

Contraction o f the FGFR2-IgIIIa/c (BEK) expression domain in cases o f A pert and Pfeiffer foetal cranial ossification suggests that the m utant activation o f this receptor, by ligand - dependent or ligand - independent means, results in negative - autoregulation. This

phenom enon, resulting from different mechanisms in the two syndromes, offers a model by which to explain differences in their cranial phenotypes.

3.2.2 Introduction

A range o f m utations in three hom ologous genes encoding the fibroblast grow th factor recep to r (FG FR ) proteins 1-3 cause related syndrom ic craniofacial dysostoses. T hese syndrom es, w hich variably feature craniosynostosis, facial dysm orphism , and extracranial m anifestations, were initially identified as frequent phenotypic clusters. A p e rt syndrom e (Apert, 1906) features a narrow range o f craniofacial dysm orphism including: pterional in drawing, a m arkedly foreshortened skull base, turribrachycep haly, severe m idfacial retrusion w ith hypertelorism ; and coronal sutural synostosis, w ith a widely unossified m edian sagittal diastem a in place o f m etopic and sagittal sutures (K reiborg and C ohen, Jr., 1990;K reiborg et al, 1993;Cohen and K reiborg, 1994). T h e characteristic A p ert cranial p h en otype reflects a narrow m utational range w ithin the F G F R 2 gene. T w o neighbouring ‘linker region’ m utations in the I g llla extracellular subdom ain o f F G F R 2 cause 98% A pert cases (Wilkie et al, 1995a) as a result o f Hgand - dependent ‘gain o f function’ (A nderson et al, 1998c).

By contrast, the related syndrom es o f C rouzon, Pfeiffer, and Jackson W eiss show a m ore variable and overlapping craniofacial dysm orphism . T he basicranial sutures generally fuse earlier than in A pert syndrom e, and the m etopic and sagittal sutures form and fuse w ithout the unossified m edian diastem a (K reiborg et al, 1993;CinaUi et al, 1995). F urth erm o re, facial retrusion may range from negligible to severe; and may variably effect the supraorbital or m idfacial skeleton, w ith m inimal pterional in drawing. T he phenotypic variability w ithin and betw een these syndrom es reflects their m utational base. A wide range o f m utations

encom passing the extracellular and transm em brane dom ains o f F G F R 2 causes the ‘C rouzon — P feiffer’ group o f syndrom es, w ith greatest frequency in the I g lllc subdom ain o f the F G F R 2 -Ig IIIa /c (BEK) splice variant (Burke et al, 1998). M any o f these m utations result in the creation o r rem oval o f an unpaired cysteine residue, o r affect a neighbouring site to cause conform ational change and confer Hgand independent functional gain (N eüson and Friesel, 1995;Neilson and Friesel, 1996;Galvin et al, 1996;Mangasarian et al, 1997;R obertson et al, 1998). Previous investigation o f m u tan t F G F R 2 signalling has been undertaken in m odel systems w hich lack the profile o f co factors and signalHng m olecules th at is endogenous to hum an tissue. T hese studies cannot, therefore, directly inform attem pts at cHnical

gen o ty p e /p h en o ty p e correlation.

A series o f F G F R expression studies in norm al hum an foetal and infant parietal osteogenesis is reported, and contrasted w ith cases o f A p ert (FG FR 2 — P250R) and Pfeiffer (F G F R 2 — C278F) cranial m orphogenesis. T he two different m utations, previously fo u n d by — w’/ro analyses to have different m odes o f activation, have similar effects u p o n the /« — siïu

expression o f FG FR2. Taken together, previous m — vitro and the current in — situ analyses in hum an tissues m ay provide a m olecular basis for their differences in craniofacial form .

3.2.3 Materials & Methods